Kitagami K, Hozumi N, Ochi A
Cell Immunol. 1987 Sep;108(2):438-51. doi: 10.1016/0008-8749(87)90226-7.
In order to investigate T cell-B cell interactions we constructed monoclonal, antigen-specific T- and B-cell populations. The Ia+ B-cell lymphoma A20-2J was transfected with trinitrophenyl (TNP)-specific heavy (mu) and light (kappa) chain Ig genes. A hapten-carrier complex (TNP-keyhole limpet hemocyanin (KLH)) bound to the surface Ig expressed on the transfectant and was presented to carrier-specific T-cell hybridoma clones at markedly low doses of antigen (0.01 microgram/ml) and in an Ia-restricted fashion. Two responses were elicited in the responding T-cell clones: (i) high levels of IL-2 secretion (320 units/ml), and (ii) cytotoxicity directed against the antigen-presenting B cell. This cytotoxicity was inhibited by D-mannose and was directed against innocent bystander cells, unlike cytotoxicity mediated by NK cells or alloreactive cytotoxic T lymphocyte. Helper and cytotoxic functions were often present in different T-cell hybridomas but some clones exhibited both activities. One representative T-cell hybridoma exhibited strong helper function for TNP-primed splenic B cells as detected in a plaque-forming cell assay, but was cytotoxic toward antigen-presenting B cells. Such monoclonal assay systems for studying cognate interactions of heterogeneous T cells and specific antigen-presenting cells will provide us with valuable new approaches for the study of antigen-specific T-cell regulation of B-cell activation in immune responses.
为了研究T细胞与B细胞的相互作用,我们构建了单克隆、抗原特异性的T细胞和B细胞群体。将Ia⁺ B细胞淋巴瘤A20 - 2J用三硝基苯基(TNP)特异性重链(μ)和轻链(κ)免疫球蛋白基因进行转染。一种半抗原 - 载体复合物(TNP - 钥孔戚血蓝蛋白(KLH))与转染细胞表面表达的免疫球蛋白结合,并以极低剂量的抗原(0.01微克/毫升)以Ia限制的方式呈递给载体特异性T细胞杂交瘤克隆。在应答的T细胞克隆中引发了两种反应:(i)高水平的白细胞介素 - 2分泌(320单位/毫升),以及(ii)针对抗原呈递B细胞的细胞毒性。这种细胞毒性被D - 甘露糖抑制,并且是针对无辜旁观者细胞的,这与自然杀伤细胞或同种异体反应性细胞毒性T淋巴细胞介导的细胞毒性不同。辅助和细胞毒性功能通常存在于不同的T细胞杂交瘤中,但一些克隆同时表现出这两种活性。在空斑形成细胞试验中检测到,一种代表性的T细胞杂交瘤对TNP预致敏的脾B细胞表现出强大的辅助功能,但对抗原呈递B细胞具有细胞毒性。这种用于研究异质性T细胞与特异性抗原呈递细胞同源相互作用的单克隆检测系统,将为我们研究免疫应答中B细胞活化的抗原特异性T细胞调节提供有价值的新方法。